Updated: May 31, 2024
The average CRISPR Therapeutics stock price target is 79.13 with a max estimate of 105.00 and a min estimate of 50.00
Review CRISPR Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: May 31, 2024